FlaggedRx← Medication recall checkHome
Class III · Lower riskActive recall

Javygtor

Unlikely to cause harm — often a labeling or packaging issue.

Does this affect you?
Check your lot numberLot #: T2300653, Exp 01/31/2025; T2303956, T2303750, Exp 06/30/2025; T2304190, T2304987, Exp 08/31/2025; T2302026, Exp 03/31/2025; T2302526, Exp 05/31/2025.
Where it was soldU.S. Nationwide
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.

What happened

Failed Impurities/Degradation Specifications

What to do

  1. Check the lot number and expiry on your medicine against the recall above.
  2. Talk to your pharmacist or doctor before changing anything — don't stop on your own.
  3. Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).

Who makes it

Made byMade in India foreign manufacturer
Brand nameJAVYGTOR
Generic nameSAPROPTERIN DIHYDROCHLORIDE
Active ingredient(s)SAPROPTERIN DIHYDROCHLORIDE
Distributed by / forDr. Reddy's Laboratories, Inc.
NDC43598-096-04
Show the full FDA record
Full product labelJavygtor (sapropterin dihydrochloride) Tablets 100mg, 120-count bottle, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 Made in India, NDC 43598-096-04.
Recalling firmDr. Reddy's Laboratories, Inc.
DistributionU.S. Nationwide
Quantity7,233 bottles
Recall initiated2024-11-22
Report date2024-12-18
Recall completed
Recall numberD-0117-2025
ClassificationClass III
FDA statusOngoing
Origin on filePrinceton NJ United States

Related

Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗

This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.